116 related articles for article (PubMed ID: 9988726)
1. Role of the intronic elements in the endogenous immunoglobulin heavy chain locus. Either the matrix attachment regions or the core enhancer is sufficient to maintain expression.
Wiersma EJ; Ronai D; Berru M; Tsui FW; Shulman MJ
J Biol Chem; 1999 Feb; 274(8):4858-62. PubMed ID: 9988726
[TBL] [Abstract][Full Text] [Related]
2. Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions.
Oancea AE; Berru M; Shulman MJ
Mol Cell Biol; 1997 May; 17(5):2658-68. PubMed ID: 9111336
[TBL] [Abstract][Full Text] [Related]
3. Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions.
Sakai E; Bottaro A; Davidson L; Sleckman BP; Alt FW
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1526-31. PubMed ID: 9990057
[TBL] [Abstract][Full Text] [Related]
4. Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-muNR enhancer repressor. Implications for regulation of immunoglobulin heavy chain expression.
Zong RT; Scheuermann RH
J Biol Chem; 1995 Oct; 270(41):24010-8. PubMed ID: 7592598
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the IgH intronic enhancer and associated matrix-attachment regions decreases, but does not abolish, class switching at the mu locus.
Bottaro A; Young F; Chen J; Serwe M; Sablitzky F; Alt FW
Int Immunol; 1998 Jun; 10(6):799-806. PubMed ID: 9678761
[TBL] [Abstract][Full Text] [Related]
6. A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activation.
Chakraborty T; Perlot T; Subrahmanyam R; Jani A; Goff PH; Zhang Y; Ivanova I; Alt FW; Sen R
J Exp Med; 2009 May; 206(5):1019-27. PubMed ID: 19414554
[TBL] [Abstract][Full Text] [Related]
7. [Human immunoglobulin heavy-chain gene intronic enhancer segment HE2 (microB) functions as a major B-cell specific cis-element at cellular level as well as in transgenic mice].
Enjoji M
Fukuoka Igaku Zasshi; 1992 Jun; 83(6):262-74. PubMed ID: 1511952
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative transcriptional states of a variegating immunoglobulin heavy chain (IgH) locus are maintained by a cis-acting epigenetic mechanism.
Ronai D; Berru M; Shulman MJ
J Immunol; 2002 Dec; 169(12):6919-27. PubMed ID: 12471125
[TBL] [Abstract][Full Text] [Related]
9. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line.
Porton B; Zaller DM; Lieberson R; Eckhardt LA
Mol Cell Biol; 1990 Mar; 10(3):1076-83. PubMed ID: 2106067
[TBL] [Abstract][Full Text] [Related]
11. Cis-acting regulatory sequences promote high-frequency gene conversion between repeated sequences in mammalian cells.
Raynard SJ; Baker MD
Nucleic Acids Res; 2004; 32(19):5916-27. PubMed ID: 15528639
[TBL] [Abstract][Full Text] [Related]
12. V(D)J recombination frequency is affected by the sequence interposed between a pair of recombination signals: sequence comparison reveals a putative recombinational enhancer element.
Roch FA; Hobi R; Berchtold MW; Kuenzle CC
Nucleic Acids Res; 1997 Jun; 25(12):2303-10. PubMed ID: 9235545
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
14. Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells.
Sigurdardottir D; Sohn J; Kass J; Selsing E
J Immunol; 1995 Mar; 154(5):2217-25. PubMed ID: 7868895
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of IgH intronic enhancer functions via germ-line deletion.
Perlot T; Alt FW; Bassing CH; Suh H; Pinaud E
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14362-7. PubMed ID: 16186486
[TBL] [Abstract][Full Text] [Related]
16. Evidence for transient requirement of the IgH enhancer.
Klein S; Gerster T; Picard D; Radbruch A; Schaffner W
Nucleic Acids Res; 1985 Dec; 13(24):8901-12. PubMed ID: 3936022
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus.
Chen J; Young F; Bottaro A; Stewart V; Smith RK; Alt FW
EMBO J; 1993 Dec; 12(12):4635-45. PubMed ID: 8223473
[TBL] [Abstract][Full Text] [Related]
18. Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.
Peng C; Eckhardt LA
J Immunol; 2013 Oct; 191(8):4399-411. PubMed ID: 24058175
[TBL] [Abstract][Full Text] [Related]
19. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
20. Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer.
Lin D; Ippolito GC; Zong RT; Bryant J; Koslovsky J; Tucker P
Mol Cancer; 2007 Mar; 6():23. PubMed ID: 17386101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
